$27.8 Billion Amgen and Horizon Merger Gets FTC Go-Ahead with Consent Order

After dropping its challenge to the proposed transaction last week, the FTC will allow Amgen’s $27.8 billion buyout of Horizon Therapeutics to proceed under terms set in a consent order — while six state attorneys general also announced they will dismiss their challenges to the deal.
Source: Drug Industry Daily